The SeriousTraders Newsletter

The SeriousTraders Newsletter If you are Serious about Trading, become a SeriousTrader!™

Newsletter Archives

SeriousTradersSpotlight Company

IGC Pharma Inc. (NYSE American: IGC)

Investment Considerations IGC’s leading drug candidate, IGC-AD1, has completed Phase 1 of a safety and tolerability trial and entered Phase 2 trials for treating agitation in patients with Alzheimer’s dementia. As of September 2022, the IGC trial is the only ongoing Phase 2 trial of a natural THC based formulation on Alzheimer’s patients. The company’s … Continue reading “IGC Pharma Inc. (NYSE American: IGC)”

View Profile

Latest Press Releases

Filter Releases
Filters
Sector



Symbol Release Time
{{ release.qmtopics.qmsymbol[0].symbol }} {{ release.headline }} {{ release.datetime | amDateFormat:'hh:mm A'}}
IBN (InvestorBrandNetwork)

SeriousTraders is part of the IBN (InvestorBrandNetwork). Other brands within the investor brand network include:

CannabisNewsWire (CNW)
CryptoCurrencyWire (CCW)
MissionIR (MIR)
NetworkNewsWire (NNW)
QualityStocks (QS)
QualityStocksTwits
StocksToBuyNow (STBN)
SmallCapRelations (SCR)
Tip.us
TraderPower (TP)
Interested in a live, online demonstration?

Schedule a LIVE Demo